Replies to post #732544 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

And once more,

Every such deal with a BP that I have heard is announced even though the milestones are conditional,.

I have never heard of any such deal that was not announced because of this conditional nonsense.

Have you ever heard of any deal by a BP to partner a drug that had not been announced when signed?

Crickets in advance.

[skitahoe]

Purely as a hypothetical, let's say that 5 years ago LP met with the CEO and others from Merck and agreed that they'd sell 20% or NWBO's shares to them for $20 a share once NWBO's share price sustained a price over $10 for 30 consecutive days. This agreement was formalized.

Nothing material had actually yet occurred, NWBO could indicate a future intent to partner with a BP, but nothing need be revealed about a formal agreement having been reached.

It's likely the agreement would actually prevent any mention until certain terms have been met. My point is that things may happen years, even decades before key events occur that aren't announced until those key events occur. If they never occur it's as if they never happened.

I have no idea if anything like this exists, however I do believe that LP has informally established how highly she believes the company should be valued before she'd consider either an equity partner or buyout. The price for a buyout is probably substantially higher than that of an equity partnership.

I believe that the BP's know that she has sufficient control that a hostile bid at less than she'd take would be defeated, but would almost certainly drive the share price up substantially. I'm not suggesting that she has enough shares herself to insure this, but rather shares are in the hands of people she trusts to follow her guidance that she doesn't need to worry about a vote against what she recommends.

When IMGN was bought out, I was one of many who believed they sold to soon. It was clear they had the agreement of Institutions who owned the majority of the shares and a fight was useless.

Gary

[LessIsMore]

there is no contract NWBO can PR YET because the condition is not met YET

This is just pure speculation, it's also speculation that NWBO CAN PR the contingent contract.

The problem here is that LP/LG have zero credibility with the majority of investors, time and again they have used legalese which allows the internet army (dolphin, both DD, fake Dr, bioharm, etc...) to dot connect to their hearts content. NWBO is not deserving of the benefit of the doubt, those who believe they do should not be investing in the stock market.

Around 5 years ago Lyin' Les Goldman used disgraced blogger Chris LaCoursiere to pump an imminent contract with BP which would include an upfront payment and contingent milestone payments. The internet army (see main culprits above) ran with it for weeks. Finally, the news was released in which Merck had agreed to supply Keytruda free of charge for an upcoming combo trial. No cash and no contingent payments (of course the internet army proclaimed this as great news because Merck was just waiting to buy NWBO, why would they throw money at a takeover).

Just a few days ago Merck announced a license agreement, this is how news should be delivered. Please notice that milestone payments include a contingency on regulatory approval. The bottom line is that NWBO could give specifics on this contract but chose not to. Why they chose not to is subject to speculation. We disagree on why they chose not to which is fine, that's what makes a market there DD. Best of luck to you!

Under the agreement, LaNova has granted Merck an exclusive global license to develop, manufacture and commercialize LM-299. LaNova will receive an upfront payment of $588 million. LaNova is also eligible to receive up to $2.7 billion in milestone payments associated with the technology transfer, development, regulatory approval and commercialization of LM-299 across multiple indications.

[Steady_T]

Dennisdave, Have you read the contract? If not, don't be so sure of the terms.